A comparison of South African national HIV incidence estimates: A critical appraisal of different methods

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Rehle, Thomas ^a,b   Johnson, Leigh ^b   Hallett, Timothy ^c   Mahy, Mary ^d   Kim, Andrea ^e   Odido, Helen ^f   Onoya, Dorina ^a   Jooste, Sean ^a   Shisana, Olive ^a,b   Puren, Adrian ^g   Parekh, Bharat ^e   Stover, John ^h  

^a HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNAIDS   (Switzerland)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNAIDS   (South Africa)

^g NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^h AVENIR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ATAZANAVIR; DARUNAVIR; EFAVIRENZ; LOPINAVIR; NEVIRAPINE; ZIDOVUDINE;

ADOLESCENT; ADULT; ARTICLE; ASSAY; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIMITING ANTIGEN AVIDITY ASSAY; MALE; MATHEMATICAL MODEL; PREVALENCE; SOUTH AFRICA; TREND STUDY; VALIDATION STUDY; VIRAL LOAD TESTING; ALGORITHM; COMPARATIVE STUDY; HIV INFECTIONS; MIDDLE AGED; THEORETICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; ALGORITHMS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, THEORETICAL; SOUTH AFRICA; YOUNG ADULT;

EID: 84942288033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133255     Document Type: Article

References (38)

1. UNAIDS (2014) UNAIDS Gap report. Geneva: UNAIDS.
2. National Department of Health (2012) The National antenatal sentinel HIV and syphilis prevalence survey, South Africa, 2011. Pretoria: NDOH
3. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, et al. (2014) South African National HIV Prevalence, Incidence, and Behaviour Survey, 2012. Cape Town: HSRC Press.
4. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W (2007) National HIV incidence measures - new insights into the South African epidemic. South African Medical Journal 97: 194-199. PMID: 17440667
5. Rehle TM, Hallett TB, Shisana O, Pillay-van Wyk V, Zuma K, Carrara H, et al. (2010). A decline in new HIV infections in South Africa: Estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS ONE 5(6): e11094. doi: 10.1371/journal.pone.0011094 PMID: 20559425
6. WHO Technical Working Group on HIV Incidence Assays (2011). When and how to use assays for recent infection to estimate HIV incidence at a population level.Geneva: WHO/UNAIDS.
7. Incidence Assay Critical Path Working Group (2011) More and better information to tackle HIV epidemics: Towards improved HIV incidence assays. PLoS Med 8(6): e1001045. doi: 10.1371/journal.pmed.1001045 PMID: 21731474
8. Brown T, Bao L, Raftery AE, Solomon JA, Bagaley RF, Stover J, et al. (2010) Modelling HIV epidemics in the antiretroviral era: the UNAIDS Estimation and Projection Package 2009. Sex Transm Infect 86(Suppl 2):ii3eii10. doi: 10.1136/sti.2010.044784
9. Stover J, Brown T, Marston M. (2012) Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Trans Infect 88:i11-ii16. doi: 10.1136/sextrans-2012-050640
10. Johnson L (2014) THEMBISA version 1.0: A model for evaluating the impact of HIV/AIDS in South Africa. Centre for Infectious Disease Epidemiology and Research, University of Cape Town. Available: http://www.cider.uct.ac.za/publications/publications-rep.php.
11. Phillips AE, Gomez GB, Boily MC,Garnett GP (2010) A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low- and middle-income countries. International Journal of Epidemiology 39: 1541-55. doi: 10.1093/ije/dyq114 PMID: 20630991
12. Hallett TB, Zaba B, Todd J, Lopman B, Mwita W, Biraro S, et al. (2008) Estimating incidence from prevalence in generalised HIV epidemics: methods and validation. PLoS Med 5: e80. doi: 10.1371/journal.pmed.0050080 PMID: 18590346
13. Hallett TB, Stover J, Mishra V, Ghys P, Gregson S, Boerma T. (2010) Estimates of HIV incidence from household-based prevalence surveys. AIDS 24(1): 147-152. doi: 10.1097/QAD.0b013e32833062dc PMID: 19915447
14. Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, et al. (2012). Detection of recent HIV-1 infection using a new Limiting-Antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PloS ONE 7(3): e33328. doi: 10.1371/journal.pone.0033328 PMID: 22479384
15. Duong YT, Kassanjee R, Welte A, Morgan M, De A, Dobbs T, et al. (2015) Recalibration of Limiting Antigen Avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes. PLoS ONE 10(2): e0114947. doi: 10.1371/journal.pone.0114947 PMID: 25710171
16. Kassanjee R, McWalter TA, Bärnighausen T, Welte A (2012) A new general biomarker-based incidence estimator. Epidemiology 23: 721-728. doi: 10.1097/EDE.0b013e3182576c07 PMID: 22627902
17. National Department of Health (2013) District Health Information System, November 2013. Pretoria: NDOH.
18. Johnson LF (2012) Access to antiretroviral treatment in South Africa, 2004-2011. Southern African Journal of HIV Medicine 13: 22-27.
19. Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, et al. for the International Epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration (2012) Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: A Multicentre Cohort Survey. PLoS Medicine, 9 (9): e1001304. doi: 10.1371/journal.pmed.1001304 PMID: 22973181
20. Lodi S, Phillips A, Touloumi G, Geskus R, Meyers L, Thiébaut R, et al. on behalf of the CASCADE Collaboration in EuroCoord (2011) Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 cells/mm3: Assessment of need following changes in treatment guidelines. Clin Infect Dis. 53 (8): 817-825. doi: 10.1093/cid/cir494 PMID: 21921225
21. Kirkwood B and Sterne JAC (2003) Essential Medical Statistics ( Second Edition): Blackwell Science.
22. Bao L, Solomon JA, Brown T, Raftery AE, Hogan DR (2012) Modelling national HIV/AIDS epidemics: revised approach in the UNAIDS Estimation and Projection Package 2011, Sex Transm Infect 88:i3-i10. doi: 10.1136/sextrans-2012-050637
23. Hogan DR, Solomon JA (2012) Spline-based modelling of trends in the force of HIV infection, with application to the UNAIDS Estimation and Projection Package, Sex Transm Infect 88:i52-i57. doi: 10.1136/sextrans-2012-050652 PMID: 23172346
24. Johnson LF, Dorrington RE, Bradshaw D, Pillay-Van Wyk V, Rehle TM (2009) Sexual behaviour patterns in South Africa and their association with the spread of HIV: insights from a mathematical model. Demographic Research 21: 289-340.
25. Johnson LF, Hallett TB, Rehle TM, Dorrington RE (2012) The effect of changes in condom usage and antiretroviral treatment coverage on HIV incidence in South Africa: a model-based analysis. Journal of the Royal Society Interface 9: 1544-54.
26. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al. (2011) Estimating HIV incidence among adults in Kenya and Uganda: a systematic comparison of multiple methods. PLoS ONE 6(3): e17535. doi: 10.1371/journal.pone.0017535 PMID: 21408182
27. Busch MP, Pilcher CD, Mastro T, Kaldor J, Vercauteren G, Rodriguez W, et al. for the WHO Working Group on HIV Incidence Assays (2010) Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS, 24: 2763-2771. doi: 10.1097/QAD.0b013e32833f1142 PMID: 20975514
28. WHO/UNAIDS (2013) Technical update on HIV incidence assays for surveillance and epidemic monitoring. Geneva: WHO/UNAIDS.
29. Longosz AF, Mehta SH, Kirk GD, Margolick JB, Brown J, Quinn T, et al. (2014) Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS Feb 6. [Epub ahead of print].
30. Fogel JM, Wang L, Parsons TL, Ou SS, Piwowar-Manning E, Chen Y, et al. (2013) Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052). J Infect Dis. 15; 208(10): 1624-1628.
31. Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, et al. (2014) Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 58(1):117-20. doi: 10.1093/cid/cit672 PMID: 24092804
32. Kahle EM, Kashuba A, Baeten JM, Fife KH, Celum C, Mujugira A, et al. for Partners in Prevention HSV/HIV Transmission Study Team (2014) Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study. J Acquir Immune Defic Syndr. 65(2):e90-94. doi: 10.1097/QAI.0b013e3182a2db02 PMID: 24442233
33. Kassanjee R, Pilcher CD, Keating SM, Facente SN, Mckinney E, Price M, et al. (2014) Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS Aug19 [Epub ahead of print].
34. Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA, Available: http://www.incidence-estimation.org/page/cephia). Confidential presentation and private communication, WHO and CEPHIA Working Group on HIV Incidence Assays, Barcelona, Spain, 13-15 October, 2014.
35. Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, et al. (2013) Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States. PLoS ONE 8(12): e82772. doi: 10.1371/journal.pone.0082772 PMID: 24386116
36. Hatano H, Bacon O, Cohen S, Liu A, Buchbinder S, Chomont MK, et al. Lack of detectable HIV DNA in a PrEP study participant during "hyperacute" HIV infection. 21st Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014; Boston, Massachusetts. Abstract 397LB.
37. Duong YT, Mavengere Y, Patel H, Moore C, Manjengwa J, Sibandze D, et al. (2014) Poor performance of the Determine 4th generation HIV 1/2 Ag/Ab combo rapid test to detect acute infections in a national household survey in Swaziland. J Clin Microbiol. doi: 10.1128/JCM.01989-14. Aug 13 [Epub ahead of print].
38. South African National AIDS Council (2011). National strategic plan on HIV, STIs and TB 2012-2016. Pretoria: SANAC.